Internal Radiation Therapy Plus Carmustine Implants in Treating Patients With Recurrent or Refractory Malignant Glioma
Status:
Completed
Trial end date:
2004-05-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Internal radiation uses high-energy radiation to damage tumor cells. Drugs used in
chemotherapy use different ways to stop tumor cells from dividing so they stop growing or
die. Combining internal radiation therapy with chemotherapy implants may kill remaining tumor
cells following surgery.
PURPOSE: Phase I trial to study the effectiveness of internal radiation therapy plus
carmustine implants in treating patients who have recurrent or refractory malignant glioma.